Desmopressin tablet

Form: Tablet

Strength: 0.1 mg, 0.2 mg

Reference Brands: DDAVP(US & EU)

Category: Blood Disorder

Desmopressin tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and quality in accordance with GMP standards. In the US, the FDA regulates desmopressin products, while the EMA oversees approval in the EU. Dossiers include clinical trial data, stability, manufacturing, and safety profiles. Used primarily for diabetes insipidus, bedwetting, and bleeding disorders, desmopressin undergoes rigorous evaluation before market authorization. For detailed regulatory insights, licensing procedures, and approved dossiers of desmopressin tablets, visit Pharmatradz. Stay informed on the latest global regulatory updates for this vital therapeutic agent.